Thermo Fisher Scientific - We've completed our acquisition of PeproTech, a leading developer and manufacturer of recombinant proteins for cell and gene therapies. PeproTech's portfolio will complement our existing cell culture media
Thermo Fisher Scientific - Today represents an exciting milestone for us as we completed our acquisition of PPD - Pharmaceutical Product Development! PPD brings proven clinical drug development expertise and strong laboratory
![Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout - MedCity News Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout - MedCity News](https://medcitynews.com/uploads/2022/10/GettyImages-97206143-600x400.jpg)
Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout - MedCity News
![Thermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization Thermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization](https://mma.prnewswire.com/media/1488649/PPD_Logo.jpg)
Thermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
![CROs Remain Hot Commodity as Thermo Fisher Announces Plans for $17.4B Acquisition of PPD | Inside Precision Medicine CROs Remain Hot Commodity as Thermo Fisher Announces Plans for $17.4B Acquisition of PPD | Inside Precision Medicine](https://www.insideprecisionmedicine.com/wp-content/uploads/2020/02/0120-CO-CancerDx-GenexusTech-696x464.jpg)